(Q28581627)

English

Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation

scientific journal article

In more languages

Statements

scholarly article

1 reference

31 January 2017

Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation (English)

1 reference

31 January 2017

author name string

Tonghuan Hu

1

1 reference

31 January 2017

Michael Chouinard

2

1 reference

31 January 2017

Amy L. Cox

3

1 reference

31 January 2017

Philip Sipes

4

1 reference

31 January 2017

Marialuisa Marcelo

5

1 reference

31 January 2017

James Ficorilli

6

1 reference

31 January 2017

Shuyu Li

7

1 reference

31 January 2017

Hong Gao

8

1 reference

31 January 2017

Timothy P. Ryan

9

1 reference

31 January 2017

M. Dodson Michael

10

1 reference

31 January 2017

Laura F. Michael

11

1 reference

31 January 2017

language of work or name

0 references

publication date

29 December 2006

1 reference

31 January 2017

Journal of Biological Chemistry

1 reference

31 January 2017

281

1 reference

31 January 2017

52

1 reference

31 January 2017

39831–39838

1 reference

31 January 2017

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Retinoid x receptor heterodimers in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

LXRS and FXR: the yin and yang of cholesterol and fat metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Nuclear receptors and their relevance to diseases related to lipid metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Identification of a nuclear receptor for bile acids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Bile acids: natural ligands for an orphan nuclear receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Nuclear orphan receptors control cholesterol catabolism.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Transient impairment of the adaptive response to fasting in FXR-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Farnesoid X receptor is essential for normal glucose homeostasis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Regulation of carbohydrate metabolism by the farnesoid X receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Blocking NO synthesis: how, where and why?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

The human liver clears both asymmetric and symmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Fenofibrate increases the L-arginine:ADMA ratio by increase of L-arginine concentration but has no effect on ADMA concentration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Expression and activation of the farnesoid X receptor in the vasculature

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606779200

21 January 2018

Identifiers

10.1074/JBC.M606779200

1 reference

31 January 2017

1 reference

31 January 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28581627&oldid=1049064613"